. 2022 Dec 17;23(24):16109. doi: 10.3390/ijms232416109

Table 1.

Summary of pre-existing and newly developed imaging modalities for inflammation, fibrosis, and cancer in the GI tract.

Disease		Modality	Citation
Inflammation	IBD	Endoscopy and Convolution Neural Network (CNN)	[38]
		Endoscopy	[39]
		Endoscopy and Deep Learning CNN	[40]
		Computed Tomography (CT) Enterography	[41]
		Magnetic Resonance (MR) Enterography	[42]
		MR Enterography: Diffusion Weighted Imaging	[43]
		Chromoendoscopy	[44]
		Transabdominal Ultrasound	[45]
		¹⁸F-FDG Positron Emission Tomography (PET)/MR Enterography	[46]
		Multispectral Optoacoustic Tomography (MSOT)	[47] [48]
	Diverticulitis	Ultrasound	[49]
		Colonoscopy	[50]
		Magnetic Resonance Imaging (MRI)	[51]
		CT	[52]
	Celiac Disease	Endoscopy	[53]
		CT	[54]
		Ultrasound	[55]
Fibrosis	Graft versus Host Disease	¹⁸F-FDG PET	[56]
		MRI	[57]
		¹⁸F-FDG PET and MRI	[58]
		Ultrasound	[59]
		CT	[60]
	Intestinal Fibrosis	MRI: Diffusion Kurtosis Imaging	[61]
		CT Enterography: Radiomic Model	[62]
		CT Enterography: Deep Learning Model	[63]
		Magnetization Transfer Imaging and Native T₁ Mapping	[64]
Cancer	Gastric Cancer	Multidetector Row Computed Tomography	[65]
		MRI	[66]
		Endoscopic Ultrasound	[67]
		¹⁸F-FDG-PET/CT and Laparoscopy	[68]
		¹⁸F-FDG-PET/CT	[69]
	Colorectal Cancer	Colonoscopy and Sigmoidoscopy	[70]
		¹⁸F-FDG-PET/CT	[71]
		CT	[72]
		CT + Artificial Intelligence (AI) and MRI + AI	[73]
		MRI	[74]